Amphastar Q3 Net Income Rises to $37.8 Million as Revenue Grows 8%
Amphastar Pharmaceuticals reported on November 5, 2026 that net revenue for the third quarter ended September 30, 2026 rose 8% year over year to $207.6 million, while GAAP net income increased to $37.8 million from $17.4 million. Diluted earnings were $0.87 per share, compared with $0.37 a year earlier. The profit comparison was shaped by a sharp reduction in general and administrative expense, which fell to $16.8 million from $39.5 million. The year-earlier quarter included a $23.1 million…